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Abstract Mortality in patients admitted with sepsis is high
and the increasing incidence of infections with multiresistant
bacteria is a worldwide problem. Many hospitals have local
antimicrobial guidelines to assure effective treatment and limit
the use of broad-spectrum antibiotics, thereby reducing the
selection of resistant bacteria. We evaluated adherence to the
antimicrobial treatment guidelines of our hospital in patients
presenting to the emergency department (ED) with sepsis and
assessed the in vitro susceptibility of isolated pathogens to the
guideline-recommended treatment and the prescribed treat-
ment.Weincludedalladultpatientswithaknownorsuspected
infection and two or more extended systemic inflammatory
response syndrome (SIRS) criteria. Patients who did not
receive antimicrobial treatment, presented with infections not
included in theguidelines, or hadmore than one possible focus
of infection were excluded. A total of 276 ED visits (262
patients) were included. Guideline-concordant treatment was
prescribed in 168 visits (61%). In the case of guideline-
disconcordant treatment, 87% was more broad-spectrum than
guideline-recommended treatment. A microbiological diagno-
sis was established in 96 visits (35%). The susceptibility of the
pathogens isolated from patients treated with guideline-
concordant treatment (n=68) and guideline-disconcordant
treatment (n=28) to guideline-recommended treatment (91%
versus 89%) and to prescribed treatment (91% versus 93%)
was similar (p=0.77 and p=0.79, respectively). In
conclusion, non-adherence to the guidelines occurred
frequently and resulted in more broad-spectrum empirical
therapy. This did not result in a higher rate of susceptibility of
the isolated pathogens to the prescribed empirical therapy.
Introduction
The mortality rate in patients admitted to the emergency
department (ED) with severe sepsis and septic shock is high
[1, 2]. Early initiation of appropriate empirical antimicrobial
therapy has been shown to improve survival in patients with
sepsis and septic shock [3–7]. The choice of the empirical
antimicrobial therapy in sepsis mainly depends on the
suspected site of infection and the antimicrobial susceptibil-
ity of the expected pathogens. To include more resistant but
often less prevalent pathogens, the empirical therapy of a
severe infection is usually broad-spectrum [4, 8].
Antimicrobial treatment guidelineshavebeendevelopedto
assure effective treatment, decrease treatment diversity,
prevent treatment delay, and reduce the unnecessary use of
broad-spectrum antimicrobials, thereby reducing the selective
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differences in pathogens and antimicrobial susceptibility,
many countries and hospitals have their own antimicrobial
treatment guidelines based on local epidemiological data,
existing literature, and expert opinion. Although many
hospitals have implemented local antimicrobial treatment
guidelines, there is a wide variation in the reported adherence
to these guidelines [5, 8–10].
The local antimicrobial treatment guidelines in our hospital
have been developed, adjusted, and evaluated over the years.
The goal of our present study is to evaluate the adherence to
these guidelines in patients admitted with sepsis and the in vitro
susceptibility of the isolated pathogens to the treatment
recommended in the guidelines. When the prescribed antimi-
crobial therapy deviated from the therapy advised in the
guidelines, we compared the susceptibility of the isolated
pathogens to the prescribed treatment and the treatment
recommended in the guidelines.
Methods
Study setting
This is a retrospective cohort study of patients admitted
with sepsis to the ED of the Radboud University Nijmegen
Medical Centre, a 950-bed university hospital in the
Netherlands. Every year, approximately 20,000 patients
visit this ED, which is staffed by residents from the
departments of internal medicine (including cardiology,
pulmonology, hematology, general internal medicine, geri-
atrics, oncology, nephrology, gastroenterology, and rheu-
matology), neurology, and surgery (including orthopedics,
urology, and general surgery). Patients admitted to the ED
are often referred by their general practitioner to a specific
medical speciality, e.g., patients diagnosed with a pneumo-
nia are not exclusively referred to pulmonology but also to
other specialities of internal medicine.
All patients (≥16 years old) admitted to the ED between
November 6, 2006 and May 9, 2007 with a known or
suspected infection and at least two extended systemic
inflammatory response syndrome (SIRS) criteria (tem-
perature ≥38.3°C or <36°C, heart rate>90 bpm, respi-
ratory rate>20/min, cold chills, altered mental status,
systolic blood pressure <90 mm Hg, mean arterial
pressure <65 mm Hg, and hyperglycemia in the
absence of diabetes mellitus) were eligible for the
study [11]. Patients were excluded if they were diag-
nosed with an infection not included in the local
antimicrobial treatment guidelines, if they did not receive
antimicrobial therapy, or if the physician considered >1
specific site of infection (the guidelines do not provide an
antimicrobial policy for these situations).
Antimicrobial treatment guidelines
Over the years, the antibiotic committee of our hospital,
including a pharmacist, a medical microbiologist, and several
clinical specialists, have developed antimicrobial treatment
guidelines for the most common types of infection. The first
version oftheseguidelineswas introduced morethan10years
ago as a booklet and was distributed among all clinicians
throughout the hospital. Since then, many guideline revisions
have been made. The latest editions of the guidelines have
been available as an easily accessible and easy-to-use
electronic version on the hospital intranet, available on every
computer in the hospital, and a PDA version can be
downloaded. Table 1 is a summary of the guideline
recommendations during the study period.
Data collection
Patient demographics, clinical diagnosis with respect to the
site of infection, the prescribed antimicrobial therapy at the
ED and the medical speciality of the prescribing physician,
intensive care unit (ICU) admission within the first 24 h, and
length of stay were retrieved from the patient files. The all-
cause 30-day mortality was assessed by chart review. When
this follow-up was incomplete, the municipal administration
and, when necessary, the general practitioner was consulted.
When the physical examination, laboratory results, and
imaging results failed to identify a site of infection, the
diagnosis was defined as sepsis of unknown origin. As the
choice of therapy is based on the clinical diagnosis as well
as factors such as where the infection is contracted
(community, hospital, nursing home), previous adverse
reactions on antimicrobial therapy, prior antimicrobial use,
and culture results, the complete medical charts were
reviewed for motivations for therapy adjustments in case
of guideline-disconcordant treatment [12].
Informationaboutculturecollectionandcultureresultswas
retrieved from the laboratory information system. The clinical
significance of culture results was assessed taking into
account the clinical information and the quality of the
specimen. Bacteria isolated from blood or other sterile body
sites were always considered to be significant, except when
the isolate is known as a common skin contaminant. In
addition, the clinical significance was evaluated by a
microbiologist based on the culture results, clinical diagnosis,
and response to antimicrobial therapy.
Isolates from sputum were considered to be significant if
the sputum sample had <10 squamous cells and >25
leukocytes per low-power field. In patients with a clinical
diagnosis of urosepsis, bacteria in concentrations of >10
5/
ml urine were considered to be significant in the presence
of leukocyturia without significant epithelial cells. Clinical
significance was evaluated from the patient file if bacterial
1562 Eur J Clin Microbiol Infect Dis (2012) 31:1561–1568counts were in the range 10
4–10
5/ml and in case of a
monobacterial culture with bacteria >10
5/ml in the presence
of leukocyturia and epithelial cells. In patients with a
diagnosis of skin/wound infection, isolates of true pathogens
such as beta-hemolytic streptococci or Staphylococcus aureus
were considered to be significant, and the significance of
Gram-negative bacteria was determined from investigation of
the patient file.
Guideline adherence
The prescribed antimicrobial therapy was divided into “guide-
line-concordant treatment” and “guideline-disconcordant treat-
ment”. Guideline-concordant treatment was defined as
antimicrobial therapy prescribed empirically in accordance
with the clinical diagnosis at the ED and the antimicrobial
treatment guideline. Complete medical charts were reviewed
for motivations for therapy adjustments in case of guideline-
discordant treatment. When physicians deviated from the
guideline-recommended treatment with good motivation, such
as the presence of a known allergy or previously cultured
pathogens, the therapy was considered to be guideline-
concordant.
Antimicrobial susceptibility
Based on the in vitro susceptibility results (using Clinical and
Laboratory Standards Institute [CLSI] breakpoints) of the
isolated pathogens, we evaluated the appropriateness of the
guideline-recommended treatment as well as the prescribed
therapy. Pathogens were considered resistant to antimicrobial
therapy when at least one of the isolated micro-organisms
categorized as a relevant pathogen was tested resistant by
routine in vitro susceptibility testing or was intrinsically
resistant to the antimicrobial therapy.
Statistical analysis
We compared the patient demographics and characteristics
in patients treated with guideline-concordant treatment and
guideline-disconcordant treatment. Categorical variables
were analyzed using Pearson’s Chi-squared test and
continuous variables were analyzed using Student’s t-test
or the Mann–Whitney U-test, as applicable. A p-value of
less than 0.05 was considered to be statistically significant.
All calculations were performed using SPSS software,
version 16.0 for Windows (SPSS Inc., Chicago, IL).
Results
Of a total of 400 ED visits with a known or suspected infection
and≥2 extended SIRS criteria, 276 visits (262 patients) were
included in the study (Fig. 1). The mean (± standard deviation
[SD]) age was 59±19 years and 63% were male. Blood
cultures were positive in 49 patients (18%; contaminated
blood cultures not included) and 22 patients were admitted to
the ICU within 24 h after admission (8%). The length of stay,
Table 1 Empirical antimicrobi-
al treatment guideline recom-
mendations for the most
common infections
a“Recent” was not specifically
defined in the guidelines
bSeverity determined by the
CURB-65 score: each risk fac-
tor scores 1 point: confusion,
urea >7 mmol/L (19 mg/dL),
respiratory rate ≥30/min, blood
pressure systolic ≤90 mmHg
and/or diastolic ≤60 mmHg ,
age 65 years or older. A pneu-
monia was considered to be
mild when the score was 0–1
and severe when the score
was≥2
Diagnosis Guideline-recommended treatment
Urosepsis Ceftriaxone 1 g every 24 h after a 2 g loading dose
Recent antibiotic use
a Ceftazidime 1 g every 8 h
Febrile neutropenia Ceftazidime 2 g every 8 h
Meningitis Ceftriaxone 2 g every 12 h
Listeria risk factors Ceftriaxone 2 g every 12 h+amoxicillin 2 g every 4 h
Sepsis of unknown origin Ceftriaxone 2 g every 24 h
Recent antibiotic use or hospitalization
a Piperacillin–tazobactam 4.5 g every 8 h
Cholangitis Piperacillin 4 g every 8 h
Skin or soft tissue infection
Cellulitis Flucloxacillin 1 g every 4 h
Erysipelas Penicillin 1 million UI every 6 h or clindamycin 600 mg
every 8 h
Pneumonia
b
Mild Doxycycline 100 mg every 24 h after a 200-mg loading
dose OR amoxicillin 500 mg every 6 h
Severe Penicillin 1 million UI every 4 h OR penicillin 1 million
UI every 4 h+ciprofloxacin 400 mg every 12 h
Nursing home or recent antibiotic use
a Piperacillin–tazobactam 4.5 g every 8 h
Aspiration pneumonia Amoxicillin–clavulanic acid 1.2 g every 6 h
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were similar in patients receiving guideline-concordant and
guideline-disconcordant treatment (Table 2). One patient was
lost to follow-up.
Antimicrobial treatment guideline adherence
The overall adherence to the guideline-recommended
treatment was 61% (Table 3; n=168). This includes 25
ED visits where the prescribed treatment was considered to
be guideline-concordant due to a well-motivated deviation
from the guideline-recommended therapy. Adherence was
the highest in patients diagnosed with urosepsis and febrile
neutropenia (95% and 94%, respectively) and the lowest in
patients with pneumonia (43%). Among the patients with
pneumonia, adherence was above 50% in patients with
severe pneumonia, as defined by the CURB-65 score,
patients residing in a nursing home, and patients with recent
antibiotic use, whereas adherence in patients with a mild
pneumonia was only 34% [13].
In 94 of the 108 patients (87%) with guideline-
disconcordant treatment, the antimicrobial therapy was
more broad-spectrum than the guideline-recommended
therapy, and 66 patients were treated with a beta-lactam/
beta-lactamase inhibitor instead of a narrow-spectrum beta-
lactam. Treatment diversity was the highest among patients
diagnosed with a pneumonia: a total of 12 different
antibiotic regimens were prescribed in these patients.
Antimicrobial susceptibility
Positive cultures were found in 133 patients. Thirty-seven
cultures were interpreted as non-significant or contamina-
tion. These cultures consisted of Candida species, Asper-
gillus species, or Gram-negative bacteria interpreted as
colonization or contamination from 15 urine and 18 sputum
specimens, one wound swab with coagulase-negative
staphylococci, two blood cultures with coagulase-negative
staphylococci, and one Propionibacterium acnes in a
biopsy of an intracerebral lesion, later confirmed to be a
malignancy. Four cultures that led to a different definite
8570 ED visits
400 ED visits suspected infection &
             ≥2 extended SIRS criteria
276 ED visits included
124 ED visits excluded
20 visits: insufficient information
43 visits: no antibiotic therapy
32 visits: infection not included in the guidelines
29 visits: >1 possible site of infection
Fig. 1 Flow-chart of the included emergency department visits. ED:
emergencydepartment,SIRS:systemicinflammatoryresponsesyndrome
Table 2 Patient demographics
and characteristics by adherence
to guideline-recommended
treatment
ED: emergency department, BC:
blood culture, IQR: interquartile
range, LOS: length of stay
Characteristic Guideline-concordant
treatment (n=168)
Guideline-disconcordant
treatment (n =108)
p-value
Mean age, years ± SD 59±19 60±18 0.55
Male 103 (61%) 72 (65%) 0.46
Nursing home resident 10 (6%) 8 (7%) 0.63
Hospitalization in the last 3 months 51 (30%) 30 (27%) 0.65
Mean C-reactive protein ± SD 135±122 114±112 0.16
Mean lactate ± SD 2.5±1.4 2.3±1.3 0.28
BC obtained 160 (95%) 100 (93%) 0.36
Bacteremia 32 (19%) 17 (16%) 0.48
Median (IQR) LOS (days) 6 (9) 7 (8) 0.90
30-day mortality 17 (10%) 10 (9%) 0.77
ED treatment by <0.001
General surgery (16) 6 (4%) 10 (9%)
Orthopedics (2) 0 (0%) 2 (2%)
Urology (17) 17 (10%) 0 (0%)
Internal medicine (157) 109 (65%) 48 (44%)
Neurology (11) 10 (6%) 1 (1%)
Pulmonology (72) 22 (13%) 50 (45%)
Otolaryngology (1) 0 (0%) 1 (1%)
1564 Eur J Clin Microbiol Infect Dis (2012) 31:1561–1568diagnosis than the clinical diagnosis made at the ED were
left out of further analysis: two urine cultures diagnostic for
urinary tract infection and one Enterococcus faecalis
bacteremia of unknown source from patients suspected of
pneumonia, and a sputum culture from a patient suspected
of meningitis. A final microbiological diagnosis was
e s t a b l i s h e di n9 6p a t i e n t s( 3 5 % ) .T a b l e4 shows the
pathogens and their susceptibility to guideline-
recommended treatment according to the clinical diagnosis.
Of the 96 patients with a microbiological diagnosis, 68
received guideline-concordant treatment. The susceptibility
of the isolated pathogens to the guideline-recommended
treatment was similar in patients with guideline-concordant
treatment and guideline-disconcordant treatment (62/68;
91% and 25/28; 89% respectively, p=0.77). Furthermore,
the susceptibility of the isolated pathogens to the
prescribed therapy was similar in patients with guideline-
concordant treatment (62/68; 91%) and guideline-
disconcordant treatment (26/28; 93%; p=0.79).
Nine of the 96 isolated pathogens (9%) were resistant to
guideline-concordant treatment (Table 4). The percentage of
pathogens resistant to guideline-recommended treatment was
higher when an ED visit was preceded by a hospitalization in
the last 3 months (6/26; 23% versus 3/70; 4%; p=0.005).
Discussion
During the study period, the overall adherence to our local
antimicrobial treatment guidelines in patients admitted to
the ED with sepsis was 61%. However, differences between
subgroups were substantial, with high adherence rates in
patients with urosepsis and febrile neutropenia, and low
rates in patients with pneumonia, skin or soft tissue
infection, or cholangitis. The empirical therapy in patients
treated with guideline-disconcordant treatment was more
broad-spectrum than guideline-recommended treatment in
the vast majority of patients. However, this use of more
broad-spectrum antimicrobial treatment did not result in a
higher rate of in vitro susceptibility of the isolated
pathogens to the prescribed treatment in the patients with
guideline-disconcordant treatment compared to the patients
Table 3 Adherence to
guideline-recommended treat-
ment categorized by clinical
diagnosis (n=276)
Clinical diagnosis Guideline-concordant
treatment (n=168)
Guideline-disconcordant
treatment (n=108)
Urosepsis (42) 40 (95%) 2 (5%)
Recent antibiotic use (4) 4 –
Febrile neutropenia (17) 16 (94%) 1 (6%)
Meningitis (6) 5 (83%) 1 (17%)
Sepsis of unknown origin (29) 21 (75%) 8 (25%)
Recent antibiotic use or hospitalization (4) 3 1
Miscellaneous infections (19) 12 (63%) 7 (37%)
Arthritis (3) – 3
C. difficile infection (3) 1 2
Diverticulitis (2) 1 1
Pancreatitis (1) 1 –
Postpartum fever (1) 1 –
Other abdominal infections (5) 5 –
Epididymitis (1) 1 –
Endocarditis (1) 1 –
Tonsillitis (1) – 1
Brain abscess (1) 1 –
Cholangitis (7) 4 (57%) 3 (43%)
Skin or soft tissue infection (15) 8 (53%) 7 (47%)
Cellulitis (5) 3 2
Erysipelas (10) 5 5
Pneumonia (142) 62 (44%) 80 (56%)
Mild (66) 23 43
Severe (41) 22 19
Nursing home or recent antibiotic use (31) 16 15
Aspiration (4) 1 3
Eur J Clin Microbiol Infect Dis (2012) 31:1561–1568 1565with guideline-concordant treatment. In addition, the
isolated pathogens were equally susceptible to the
guideline-recommended therapy in both treatment groups.
These results indicate that non-compliance to the guideline
does not result in a clinical benefit for patients admitted
with sepsis.
A small but significant proportion (9%) of isolated
pathogens were resistant to the guideline-recommended
therapy. These pathogens were mostly cultured from
recently hospitalized patients. This is in keeping with an
earlier study that identified frequent contacts with the
healthcare system, especially recent hospitalization, prior
to admission as an important risk factor for ineffective
empirical therapy in patients admitted with a bloodstream
infection [14]. A more broad-spectrum empirical therapy
for this specific group of patients needs to be considered.
Although many hospitals have their own antimicrobial
treatment guidelines, little is known about the adherence to
Table 4 Isolated pathogens per
diagnosis (n=96) and the
pathogens which were in vitro
resistant to the guideline-
recommended treatment (n=9)
NH: nursing home resident,
ESBL: extended-spectrum beta-
lactamase
aThis patient was treated with
ceftazidime and teicoplanin
based on recent culture results
and recent antibiotic use: this
regimen was considered to be
guideline-concordant treatment
Isolated pathogens (n) Resistant to guideline therapy (n)
Urosepsis (33) Enterobacteriaceae (22)
E. faecalis (2) 2
S. aureus (3)
H. influenzae (2)
Polymicrobial (2) 2 (E. faecalis; A. baumanii)
S. epidermidis (1)
Recent antibiotic use E. faecalis (1)
a
Pneumonia (30) S. pneumoniae (13)
H. influenzae (2)
Beta-hemolytic streptococci (3)
P. aeruginosa (1)
A. baumanii (1) 1
M. catarrhalis (1)
C. propinquum (1)
Polymicrobial (1)
Aspiration pneumonia Polymicrobial (1) 1 (E. coli)
NH or recent antibiotic use S. pneumoniae (4)
H. influenzae (1)
S. aureus (1)
Skin or soft tissue (3) Beta-hemolytic streptococci (3)
Meningitis (3) S. pneumoniae (3)
Cholangitis (4) P. aeruginosa
K. oxytoca 1
S. milleri group
Polymicrobial
Sepsis of unknown origin (12) Enterobacteriaceae (8)
S. aureus (1)
C. canimorsus (1)
Polymicrobial (1) 1 (ESBL E. coli and E. faecalis)
Febrile neutropenia (6) Enterobacteriaceae (2)
Polymicrobial (2) 1 (E. faecalis)
P. aeruginosa (1)
S. pneumoniae (1)
Miscellaneous infections (5)
Endocarditis S. aureus (1)
Arthritis S. aureus (1)
C. difficile infection C. difficile (1)
Other abdominal infections E. faecium (1)
Postpartum fever S. agalactiae (1)
1566 Eur J Clin Microbiol Infect Dis (2012) 31:1561–1568these guidelines in patients with sepsis. A high adherence
of 90% to local antimicrobial therapy guidelines in patients
with a suspected or documented infection (pneumonia,
cellulitis or erysipelas, urosepsis, febrile neutropenia, or
meningitis) has been described [8]. However, the investi-
gated guidelines were developed by internal medicine
specialists for their own use in patients admitted to the
internal medicine wards or the ICU. In contrast, we
investigated the adherence to local antimicrobial treatment
guidelines developed for use in the entire hospital, in
patients admitted to the ED and treated by many different
physicians and disciplines. Our adherence data are in
agreement with other studies that investigated compliance
to treatment guidelines in patients admitted with a pneu-
monia and reported adherence rates of between 41% and
77% [3, 5, 9, 10].
The obvious downside of the unnecessary use of broad-
spectrum therapy is the increase in the selective pressure on
bacteria, thereby, promoting the emergence of resistant
pathogens [15, 16]. Over the last few decades, a dramatic
increase of bacterial resistance has emerged with the
increasing use of broad-spectrum antimicrobials, whereas,
on the other hand, the development of new antimicrobial
agents is declining [17]. The use of antimicrobial treatment
guidelines based on local epidemiology, followed by de-
escalation of the empirical antimicrobial therapy based on
culture and susceptibility results, is one of the most
important strategies to reduce the use of broad-spectrum
antimicrobial therapy and prevent and control the emer-
gence of bacterial resistance. The adherence rate to our
local antimicrobial treatment guidelines illustrates the need
for ongoing communication about culture and susceptibility
results in relation to the prescribed antimicrobial treatment
and the antimicrobial treatment guidelines. Previous re-
search has demonstrated that antimicrobial treatment
guideline adherence can be improved by close collaboration
with representatives of the involved departments and
feedback on antimicrobial use in combination with educa-
tional training sessions for physicians [18].
Our study has several limitations. First, it was a
retrospective cohort study, which implicates that reasons
for prescribing guideline-disconcordant treatment were only
taken into account when they were recorded in the patients’
medical charts. Furthermore, the study results reflect the
epidemiology and guideline adherence of a single center;
several subgroups such as patients with cholangitis and
meningitis were very small, and the miscellaneous infec-
tions were very diverse. However, the goal of our study was
to provide an overview of the antimicrobial treatment
guideline adherence and the appropriateness of prescribed
treatment among all patients admitted to the ED of our
hospital with sepsis, and we do believe that our data
provide insights into daily clinical practice. The reasons for
non-adherence to antimicrobial treatment guidelines were
beyond the scope of the current study, but factors identified
in other studies will most likely be applicable in our setting
[19]. For example, fear for an unfavorable outcome with
narrow-spectrum guideline-recommended treatment and a
lack of agreement with guidelines have been identified as
the main barriers to prescribing empirical antibiotic treat-
ment according to the recommended guidelines in patients
with community-acquired pneumonia [20].
Non-adherence to guideline-recommended treatment pre-
dominantly resulted in more broad-spectrum empirical ther-
apy. However, pathogens isolated in patients treated with
guideline-disconcordant treatment were equally susceptible to
guideline-recommended therapy and the actually prescribed
treatment. To minimize treatment diversity and the inappro-
priate use of broad-spectrum antimicrobials, prescribers
should be aware that a more broad-spectrum empirical
treatment does not result in more effective treatment, but does
increase the selection of antimicrobial resistance. A multidis-
ciplinary effort should be made to improve compliance with
local antimicrobial treatment guidelines.
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